Skip to content
Startup Directory
Total raised
$700K
1 disclosed round
Latest round
Seed
Jan 2022 · $700K
Founded
2019
Headquarters
Bengaluru
Overview

About Aarogyaai Innovations Private Limited

Tuberculosis claims more lives every year than even AIDS. Over 10 Million people are diagnosed with tuberculosis each year and about 1.7 M die. This is because doctors don’t have the tools to diagnose drug resistant tuberculosis quickly and comprehensively. AarogyaAI diagnoses drug resistant tuberculosis in a few hours, so that a patient knows exactly which drugs will work best for them. AarogyaAI has partnered with leading diagnostic labs & hospitals in India for building & validating the product.

Momentum

Growth & Risk Signals

Momentum score
10 / 100
Trend
cooling
Since last round
54 mo
Risk flag
watch

Momentum is derived from funding recency, velocity, round count and scale. Risk reflects registry status and funding staleness.

Registry

Corporate Registry

Company class
Private
Paid-up capital
₹1 L
Authorized capital
₹1 L
Registrar
RoC-Bangalore
Registered state
Karnataka
CIN
U72900KA2019PTC124835

Computer and related activities

Source: Ministry of Corporate Affairs company master (open data). Capital figures are as-of the 2021 registry snapshot, not live.

Capital

Funding Timeline

Total raised · $700K
Backers

Key Investors

4 across 1 round
Graph

Relationship Network

Explore in graph search →
Coverage

Articles about Aarogyaai Innovations Private Limited

No articles linked to Aarogyaai Innovations Private Limited yet. Editorial coverage will surface here automatically once tagged.